Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country

Chronic myelocytic leukemia in pregnancy: A case report describing successful treatment using multimodal therapy

(2011) Ramez N. Eskander et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia

(2011) Zeba Aziz et al.   LEUKEMIA & LYMPHOMA

Sustained Superior Long-Term Outcomes and Cytogenetic Responses with Imatinib Mesylate in Chronic Phase Chronic Myeloid Leukaemia: Report from a Developing Country

(2010) Z. Aziz et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

(2010) François-Xavier Mahon et al.   LANCET ONCOLOGY

Successful Pregnancy in a Patient with Chronic Myeloid Leukemia under Treatment with Imatinib

(2009) Motohiro Tsuzuki et al.   INTERNAL MEDICINE

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study

(2009) Monika Conchon et al.   Journal of Hematology & Oncology

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

(2009) A Hochhaus et al.   LEUKEMIA

The effects of imatinib on pregnancy outcome

(2008) S. M. Pye et al.   BLOOD